Skip to content
healthcare.dev

Calcium Acetate

NDC 16571-813, Calcium Acetate, capsule, from Rising Pharma Holdings, Inc..

Product NDC
16571-813
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211038
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-813 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CALCIUM ACETATE667 mg/1

Pharmacologic classes

Blood Coagulation Factor [EPC]; Calcium [CS]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]

Package NDCNDC-11Package
16571-813-2016571081320200 CAPSULE in 1 BOTTLE, PLASTIC (16571-813-20)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ce650ba5-fb42-e444-e053-2a95a90a075a
  • NADAC price for package 16571081320

    GET /v1/drugs/nadac/16571081320

Use it

Look up 16571-813 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-813 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-813. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.